Arthritis and Rheumatism Journal (1/2010) published a study which suggests that sulforaphane may offer a possible treatment option for rheumatoid arthritis (RA).

A study from the Catholic University of Korea in Seoul suggests that the sulforaphane may offer a new therapeutic approach for the treatment of chronic autoimmune arthritis.
The antiarthritic and immune regulatory effects of SFN, which were confirmed in vivo, suggest that sulforaphane may offer a possible treatment option for rheumatoid arthritis (RA).
Citation:
Kong JS, Yoo SA, [...]